July 2009 Mayo Clinic Health Letter Highlights a Positive Outlook, Bell's Palsy and Heart Valve Repair
...be as effective as other approaches. A larger study is under way.
For now, open heart surgery will continue to be the mainstay to repair and
replace heart valves. As research advances, some less-invasive approaches may be viable alternatives.
Mayo Clinic Health Letter is an eight-page mo...
St. Francis Surgeon Uses Tissue Regeneration Technology to Rebuild Patients' Heart Structures
...ng the complex structural matrix intact. Once surgically implanted, it serves as a scaffold, allowing the patient's cells to infiltrate and ultimately
replace the ECM scaffold.
While the patient continues to heal, the matrix gradually is replaced as the body reinforces and remodels the tissue. In the p...
Cepheid Receives Grant to Develop Ten-Color Real-Time PCR Detection Technology for Use in the GeneXpert(R) System
...hnology, are expected to follow.
"Our goal is to continue the transformation of the clinical mycobacteriology laboratory by making it possible to
replace time-intensive and less sensitive culture processes with rapid, sensitive, and accurate molecular techniques that that are not constrained to a centra...
SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine
...ratory, South Texas VA Medical Center. "This study is important because it emphasizes the strong tie between diabetes and heart disease, but does not
replace the need for physicians to continue to evaluate the individual needs of each patient."
"Physicians should understand the patients in the BARI-2D ...
Feldenkrais(R) Movement Institute Announces Simple Non-Surgical Solutions for Jaw and Facial Pain (TMJ)
... Movement Institute, designed the Intelligent Body(R) TMJ Program to help reverse many people's longstanding habits that create tension and stress and
replace them with healthy patterns of movement. This Program contains six lessons, each averaging 10 minutes in length. The lessons are based on the Feldenk...
March 2009 Mayo Clinic Health Letter Highlights Knee Repair Surgery, Anxiety Disorder and Preventing Blood Clots
...otherapy involves working with a therapist to identify unhealthy, negative beliefs and behaviors that contribute to anxiety and, then, learning how to
replace them with healthy, positive beliefs.
Medications, both antidepressants and anti-anxiety drugs, also can help.
Among antidepressants, the f...
For Old or Young Dialysis Patients, AV Fistulas Remain Pure Gold
...N.H. When kidneys fail -- called chronic kidney or end-stage renal disease -- treatment in the form of regular dialysis (or hemodialysis) is needed to
replace the kidney's job of ridding the body of toxic waste products to maintain fluid, electrolyte and acid-base balance. A machine is used to filter blood o...
Scientists Discover Why Teeth Form in a Single Row
...eth Formed
When we lose our baby teeth, the permanent teeth grow in to
replace them, but permanent teeth when lost are lost for good. U.S. adults aged 20 ..., but each procedure comes with disadvantages. The idea of growing teeth to
replace missing ones has captured the imaginations of scientists, with many labs in...
Archimedes Pharma Announces Successful Proof-of-Concept Results on Two Intranasal Development Projects
...confirmed that each candidate has the potential to
replace existing
formulations in high value markets. The a...ase
(PD) and illustrate the product's potential to
replace apomorphine injections.
Apomorphine, a pote... route illustrates the
potential of IN Diazepam to
replace IV and rectal products.
Diazepam, a long es...
Gallbladder Removal Through Vagina Offers Minimally Invasive Alternative
...and director of the minimally invasive surgical program at Northwestern Memorial.
"NOTES is well-received by patients and holds the potential to
replace traditional laparoscopic surgery for a wide range of procedures in the future," adds Dr. Soper.
Drs. Hungness and Soper, along with John Martin,...
Applying Clinical Findings to the Practice of Medicine
...m cells to become bone cells and make bone.
According to Dr. Yaszemski, "The osteoconductive scaffolds and osteoinductive factors are intended to
replace bone graft in these procedures. Usually, the bone graft is harvested from the patient's pelvis, and these new techniques might decrease or eliminate t...
Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
...AUC (area under the curve) of hGH-CTP as measured in primates support a potential once-weekly or bi-monthly injection frequency in humans. This would
replace the multiple injections per week that are currently required, as there is presently no long-acting hGH on the market.
"Our long-acting hGH-CTP h...
Reproductive Partners Participates in New IVF Progesterone Delivery System Study
... rates and national reputation was recently selected as a participant in a national, multi-center study exploring new progesterone delivery systems to
replace intramuscular injections. Patients going through in vitro fertilization (IVF) often describe the progesterone injections as the most difficult and p...
Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program
...ses and bioweapon pathogens. The Phase 1B clinical study of SQ109 should be initiated in Q1 2009.
SQ-109 is a new diamine antibiotic intended to
replace one or more of the current first-line anti-TB drugs and simplify patient therapy. SQ109 was granted U.S. FDA Fast Track designation and FDA/EMEA Orpha...
AstraZeneca Responds to FDA Joint Advisory Committees' Recommendation on SYMBICORT(R)
...roven asthma medications-budesonide, an inhaled corticosteroid (ICS), and formoterol, a rapid and long-acting beta2-agonist (LABA). SYMBICORT does not
replace fast-acting inhalers and should not be used to treat acute symptoms of asthma.
Important Safety Information
Long acting beta2-adrenerg...
Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer
...
Once-Daily Oral Rivaroxaban Com p ared With Subcutaneous Enoxaparin Every 12 Hours for Thro m boprophylaxis Af t er Total Knee
replace m ent: RECOR D 4
[Abstract #35]
Alexander G.G. Turpie, MD, McMaster Universit y , Hamilton, On ta rio, Canada
This stud...
New Breast Imaging Technology Targets Hard-to-Detect Cancers
... suggest that BSGI allows for the diagnosis of more and earlier
breast cancers," Dr. Brem said.
Dr. Brem pointed out that BSGI is not meant to
replace mammography, but to
be used as an adjunct to mammography. "It is an excellent tool for locating
difficult-to-detect cancers and for screening high-ris...
Pivotal Data Showed SYMBICORT(R) Improved Lung Function in Adults with COPD
...ment of asthma in patients 12 years of age and older.(6) SYMBICORT
does not
replace fast-acting inhalers and should not be used to treat acute
symptoms of asth...oterol, a rapid and long-acting beta2-agonist
(LABA).(6) SYMBICORT does not
replace fast-acting inhalers and should not
be used to treat acute symptoms of asth...
Study Found That Long Term Use of Advair Diskus(R) 250/50 Did Not Adversely Affect Bone Loss in Patients with COPD
... have a heart condition or high blood pressure before
taking Advair. Do not use Advair with long-acting beta2-agonists for any
reason. Advair does not
replace fast-acting inhalers for sudden symptoms.
For more information about Advair please visit http://www.gsk.com .
Background on COPD
An estimated 2...
Sequella Presents Data on Synergy Between Investigational New TB Drugs SQ109 and TMC207
...ently underway.
About SQ109
The company's lead drug candidate, SQ109, completing Phase I clinical
trials, is a new diamine antibiotic that could
replace one or more of the
current first-line anti-tuberculosis drugs to simplify or shorten therapy.
SQ109 was granted U.S. FDA Fast Track and FDA/EMEA Orpha...
Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
...ve reversal agent, RB007, which specifically binds to and neutralizes
RB006. The Phase IIa study (REVERSAL-PCI) is designed to assess whether
REG1 can
replace standard heparin therapy during the performance of
coronary balloon angioplasty dilatation and stenting on patients at low
risk for complications asso...
Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years
...irway narrowing) associated with chronic
obstructive pulmonary disease (COPD). COPD includes both chronic bronchitis
and emphysema.
SPIRIVA does not
replace fast-acting inhalers for sudden symptoms.
Do not swallow the SPIRIVA capsule. Only use the HandiHaler device to
take the SPIRIVA capsule. Do not use...
Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial UPLIFT
...irway narrowing) associated with chronic
obstructive pulmonary disease (COPD). COPD includes both chronic bronchitis
and emphysema.
Spiriva does not
replace fast-acting inhalers for sudden symptoms.
Do not swallow the Spiriva capsule. Only use the HandiHaler device to
take the Spiriva capsule. Do not use...
InVitria Showcases Cell Culture Productivity Enhancers at BioProcess International
...InVitria products -- Cellastim and Lacromin
-- can
replace bovine or human sources of albumin or transferrin ... -- Cellastim -- Cellastim is an albumin used to
replace bovine albumin and human albumin as a cell cul....com ) -- Lacromin -- Lacromin has been shown to
replace bovine transferrin and human transferrin in ce...
Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
...undergoing elective PCI will further confirm that REG1 has the
potential to
replace standard heparin therapy."
"In striving to meet the needs of individual p...omized Phase IIa study designated REVERSAL-PCI will assess whether REG1
can
replace standard heparin therapy during the performance of PCI with
stenting.
REG...
Vincent W. Renz Joins NewCardio as President
...ons targeting large, rapidly growing, underserved
markets. As an example the Company's initial product, QTinno(TM), promises
much-needed automation to
replace a costly, labor-intensive process in
cardiac safety assessment in clinical research; particularly in large scale
thorough QT studies that are required...
Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells
...wal, stem calls
can divide and produce others that become specialized cells. Scientists and
doctors theorize that stem cells will be able to repair or
replace damaged
or diseased cells. Clinical trials researching the potential of stem cells
from fat are ongoing in Europe and Asia. In the U.S., there are man...
'Hibernation-On-Demand' Drug Hydrogen Sulfide Significantly Improves Survival After Extreme Blood Loss
...ach of which underwent controlled hemorrhage to remove 60 percent of
their blood for three hours before re-infusion with Lactated Ringer's
solution to
replace lost blood volume.
The rats were divided into two groups. In the first group, 24 rats were
put into a controlled atmosphere of room air laced with 3...
ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
...ate, overall survival and incidence and severity of adverse
events.
About ANX-510, or CoFactor
CoFactor is a folate-based biomodulator designed to
replace leucovorin
as the preferred method to enhance the activity and reduce associated
toxicity of the widely used cancer chemotherapeutic agent 5-fluoroura...
ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results
...atological or
gastrointestinal adverse event of grade 3 or greater.
About ANX-510, or CoFactor
CoFactor is a folate-based biomodulator designed to
replace leucovorin
as the preferred method to enhance the activity and reduce associated
toxicity of the widely used cancer chemotherapeutic agent 5-FU
(5-flu...
AMT Prepares for Submission of Marketing Authorization Dossier for AMT-011 (Glybera(R))
...eriously debilitating and potentially lethal disease.
AMT-011 is a gene therapy product designed to insert a healthy gene
into the patient's body to
replace the defective gene. The product is
administered by a series of injections into muscle tissue after which the
body starts to make the missing enzyme ag...
Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma
... period,
the overall incidence of adverse events was similar between the two groups.
Important Information about Advair Diskus
Advair Diskus won't
replace fast-acting inhalers for sudden symptoms
and should not be taken more than twice a day. Advair Diskus contains
salmeterol. In patients with asthma, me...
Peptimmune Presents Early Clinical Data at European Neurological Society and Federation of Clinical Immunology Societies Meetings
...e
data, along with the significant improvements on bioavailability and
pharmacodynamic effects with PI-2301, provide further evidence that PI-2301
may
replace Copaxone as first-line therapy in relapsing remitting multiple
sclerosis," stated Thomas P. Mathers, President and CEO of Peptimmune. "We
have designe...
Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
...oagulation system. The
Phase 2a study is enrolling 26 patients undergoing elective percutaneous
coronary intervention (PCI) to assess whether REG1 can
replace standard
heparin therapy during the performance of coronary balloon angioplasty
dilatation and stenting in patients at low risk for complications
asso...
ADVENTRX Presents CoFactor Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
...nutes later by 500 mg/m2 of 5-FU as an i.v. bolus over 2-3
minutes.
About ANX-510, or CoFactor
CoFactor is a folate-based biomodulator designed to
replace leucovorin
as the preferred method to enhance the activity and reduce associated
toxicity of the widely used cancer chemotherapeutic agent 5-FU
(5-flu...
Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
...then begin to
malfunction, leading to severe clinical complications and early mortality.
ELAPRASE, which is given as a weekly infusion, is designed to
replace the
deficient iduronate-2-sulfatase enzyme.
"Approval of ELAPRASE in Brazil further demonstrates our commitment to
bringing meaningful treatments to...
Patients With Asthma and Seasonal Allergies Respond Better to Advair(R) for Their Asthma Than Singulair(TM)
...a controller,
or whose disease severity clearly warrants treatment with two maintenance
therapies.
Important Information about Advair
Advair won't
replace fast-acting inhalers for sudden symptoms and
should not be taken more than twice a day. Advair contains salmeterol. In
patients with asthma, medicines...
Adding Breast Ultrasound Screening to Mammography Reveals Cancers not Seen on Mammography Alone in Women at Increased Risk for Breast Cancer
...ce policy regarding the
coverage for breast cancer screening options. An annual mammogram is still
recommended: neither MRI nor ultrasound is meant to
replace mammography.
The study continues to follow participants to examine the potential
benefit of routine annual combination screening of mammography an...
Gene Therapy Slows Progression of Fatal Neurodegenerative Disease in Children
... NEW ROCHELLE, N.Y., May 13 /PRNewswire/ -- Gene therapy to
replace the
faulty CLN2 gene, which causes a neurodegenerative disease that is fata...be a study conducted in 10 children with LINCL who
received gene therapy to
replace the defective CLN2 gene via administration
of human CLN2 carried in an aden...
Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
... technology has the
potential to enhance the efficacy of existing vaccines,
replace current
vaccines that have a cumbersome mode of administration and enable t...tribution; expectations that TCI technology will enhance the
efficacy of or
replace or be an alternative to current injected vaccines,
expectations that TCI te...